Published: February 17, 2026 | Updated: February 24, 2026
Estimated reading time: 3 minutes
Norton Cancer Institute welcomes Kevin T. Breen, M.D., Ph.D., a physician-scientist who is dedicated to finding better treatments for one of the most challenging cancers: glioblastoma, an aggressive type of brain tumor.
Dr. Breen comes to Norton Cancer Institute with impressive experience from the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), where he’s been working to understand why some cancer treatments work for certain patients but not others.
“I gravitated toward patients with brain tumors in particular,” Dr. Breen said. “Those are the people I wanted to treat and bring new therapies for, because the way we treat glioblastoma has not changed since 2005.”
That’s two decades without a major breakthrough — and Dr. Breen is determined to change that.
Dr. Breen’s research focuses on a puzzling question: Why do some tumors respond well to immunotherapy (treatments that help your immune system fight cancer), while others don’t —even when they seem like they should?
In his recent groundbreaking study, he created a specialized mouse model of glioblastoma that did respond to immunotherapy. This model may be used in the future to help doctors identify which patients may respond to immunotherapy, sparing patients ineffective therapies and getting them to the right treatment faster. “That knowledge might better tell us which glioblastoma or other solid tumor … might really respond to specific cancer treatment, such as immunotherapy,” Dr. Breen said. “That’s the bedrock of the trials I would want to start here at Norton Cancer Institute.”
Dr. Breen is already planning to launch clinical trials for patients whose cancers have stopped responding to standard treatments. His goal is not just to match patients with existing drugs — he wants to discover entirely new treatment targets that could help future patients.
He is also looking ahead to establishing a specialized clinic focused on brain metastases (when cancer spreads to the brain from elsewhere in the body), exploring how the immune system behaves differently when fighting cancer in the brain.
A collaborative spirit and commitment to innovative research attracted Dr. Breen to Norton Healthcare and Norton Cancer Institute.“The team and the willingness to plug me in and identify whatever resources may be needed to do this level of oncology research” made Norton Healthcare stand out, he said.
While Dr. Breen’s research credentials are impressive, what really sets him apart is his approach to patient care.
“I love to get to know each of my patients to understand what their goals in life are, what’s important to them,” he said. “It matters to me that they are seeing their kids, getting outdoors and doing whatever things they love to do.”
This personal touch, combined with his rigorous, evidence-based approach from his NIH and FDA experience, means patients get both leading-edge science and compassionate care.
When he’s not in the lab or clinic, you might find Dr. Breen hitting the pavement around Louisville — he has completed seven marathons. He enjoys spending time outdoors with his wife and their dog, playing acoustic guitar and cheering on his beloved Detroit sports teams.